English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduFactor Bioscience Inc., a Cambridge, Massachusetts-based biotechnology company pioneering mRNA-based cell engineering, today announced that the United States Patent and Trademark Office (USPTO) has terminated three separate ex parte reexaminations of three U.S. patents owned by Factor.
Tag: Carcinoma
Henry Ford Health + MSU Health Sciences Funds Five Cancer Research Grants to Advance Cancer Medicine, Combat Health Disparities
Henry Ford Health + Michigan State University Health Sciences today announced its funding of five cancer research grants of up to $100,000 each. These five grants follow an initial wave of funding from the partnership, in which 18 pilot grants of up to $25,000 each were funded in May 2022.
All high-grade noninvasive bladder cancers should be considered high-risk, study suggests
Noninvasive (stage Ta) bladder cancers with “high-grade” characteristics should be considered at high risk of recurrence, concludes a study in The Journal of Urology®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.
Study of Anti-Cancer Mitochondrial Drug Shows Additional Clinical Promise
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.
Study shows how to achieve optimal treatment and improve outcomes for rare cancer patients
(Baltimore, MD) — The Institute for Cancer Care at Mercy Medical Center is pleased to announce the publication of an in-depth analysis on appendiceal goblet cell carcinomas managed with CRS/HIPEC (Cytoreductive Surgery, Hyperthermic Intraperitoneal Chemotherapy) in the Annals of Surgical Oncology. These very rare…
Aggressive features in some small thyroid tumors increase the risk for metastasis
Results from a new large-scale study show that in nearly 20 percent of patients, papillary thyroid tumors less than 1 cm in size had pathological signs of more aggressive disease that increased the risk that these patients might develop distant metastasis.